ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 91 filers reported holding ADURO BIOTECH INC in Q3 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,071,000 | -49.4% | 1,010,000 | +251.0% | 0.11% | -39.2% |
Q3 2018 | $2,115,000 | +2.1% | 287,776 | -2.8% | 0.19% | -7.9% |
Q2 2018 | $2,072,000 | -72.4% | 295,965 | -63.3% | 0.20% | -73.4% |
Q1 2018 | $7,501,000 | +281.1% | 806,534 | +336.5% | 0.76% | +204.0% |
Q3 2017 | $1,968,000 | -42.5% | 184,764 | -38.4% | 0.25% | -52.9% |
Q2 2017 | $3,420,000 | -59.8% | 300,000 | -59.8% | 0.53% | -68.9% |
Q4 2016 | $8,503,000 | +36.5% | 745,886 | +48.8% | 1.71% | +45.5% |
Q3 2016 | $6,229,000 | +7.2% | 501,155 | -2.4% | 1.17% | -5.2% |
Q2 2016 | $5,809,000 | – | 513,603 | – | 1.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 640,595 | $4,708,000 | 1.20% |
BVF INC/IL | 287,776 | $2,115,000 | 0.19% |
ORACLE INVESTMENT MANAGEMENT INC | 111,542 | $820,000 | 0.18% |
Sofinnova Investments, Inc. | 189,579 | $1,393,000 | 0.12% |
CENTAURUS FINANCIAL, INC. | 85 | $624,000 | 0.11% |
Artal Group S.A. | 550,000 | $4,043,000 | 0.10% |
Vident Investment Advisory, LLC | 305,311 | $2,244,000 | 0.09% |
Virtus ETF Advisers LLC | 61,463 | $452,000 | 0.05% |
Foundry Partners, LLC | 106,907 | $786,000 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 239,301 | $1,759,000 | 0.02% |